Tunnistetiedot

Ilaprazole Nitroso Impurity

Ei ilmoitettu · C19H17N5O3S

01Tunnistetiedot

Lazychem IDLC-17005
CAS RNEi ilmoitettu
PubChem CID176475747
Molecular formulaC19H17N5O3S
Molecular weight395.4 g/mol
IUPAC name2-(((4-Methoxy-3-methylpyridin-2-yl)methyl)sulfinyl)-1-nitroso-5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole
InChIKeyQHUNVUSKIPIIJK-UHFFFAOYSA-N

02Rakenne ja stereokemia

2D structurePubChem CID 176475747
Two-dimensional chemical structure of Ilaprazole Nitroso Impurity
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 4 rings, includes aromatic atoms, includes aliphatic carbon, contains an N-nitroso substructure. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count4
Secondary amines0
Tertiary amines0
SMILESO=NN1C(S(CC2=NC=CC(OC)=C2C)=O)=NC3=CC(N4C=CC=C4)=CC=C13
InChIEi ilmoitettu

03Stereochemistry

The published structure contains 0 defined and 1 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres1Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Tila Intiassa

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nimet ja suhteet

API ja emolääke

Ilaprazole

Epäpuhtaudet ja lähiyhdisteet

Nimet ja suhteet

    Epäpuhtaudet ja lähiyhdisteet

    06Lähteet